We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

167 hedge funds and large institutions have $287M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 30

32% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $1.12M

21% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 47

1% more funds holding

Funds holding: 165 → 167 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less capital invested

Capital invested by funds: $340M → $287M (-$52.9M)

Holders
167
Holders Change
+2
Holders Change %
+1.21%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
40
Increased
57
Reduced
47
Closed
30
Calls
$1.48M
Puts
$1.12M
Net Calls
+$359K
Net Calls Change
+$1.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$41.4M
2
KAM
Krensavage Asset Management
New York
+$10.9M
3
Millennium Management
Millennium Management
New York
+$6.03M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.55M
5
GCP
GSA Capital Partners
United Kingdom
+$2.88M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$6.78M
2
Invesco
Invesco
Georgia
-$5.41M
3
NI
Numeric Investors
Massachusetts
-$5.02M
4
TA
Teachers Advisors
New York
-$4.86M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
151
Ameritas Investment Partners
Nebraska
$21K +$22.5K +1,939 New
Creative Planning
152
Creative Planning
Kansas
$18K – – –
PAM
153
Panagora Asset Management
Massachusetts
$17K – – –
YWP
154
YorkBridge Wealth Partners
New York
$13K +$14.7K +1,267 New
BTIS
155
BB&T Investment Services
North Carolina
$11K +$9.81K +845 +722%
LIA
156
LS Investment Advisors
Michigan
$11K +$12.1K +1,040 New
WIM
157
Westside Investment Management
California
$10.3K +$11.6K +1,000 New
IA
158
IFP Advisors
Florida
$10K +$6.95K +599 +189%
FMII
159
Farmers & Merchants Investments Inc
Nebraska
$6K +$1.84K +159 +43%
Federated Hermes
160
Federated Hermes
Pennsylvania
$5K – – –
Zurich Cantonal Bank
161
Zurich Cantonal Bank
Switzerland
$5K – – –
MAM
162
Meeder Asset Management
Ohio
$4K – – –
AIM
163
Advantage Investment Management
Iowa
$3K -$77.2K -6,648 -96%
KF
164
Krilogy Financial
Missouri
$3K – – –
SPIA
165
Steward Partners Investment Advisory
New York
$3K – – –
GT
166
Glenmede Trust
Pennsylvania
$2K – – –
ASN
167
Advisory Services Network
Georgia
$1K +$638 +55 New
UOC
168
UBS O'Connor
Illinois
– -$6.78M -500,000 Closed
SCM
169
Stonepine Capital Management
Oregon
– -$3.85M -284,002 Closed
Fidelity Investments
170
Fidelity Investments
Massachusetts
– -$2.24M -165,400 Closed
Point72 Asset Management
171
Point72 Asset Management
Connecticut
– -$1.8M -133,100 Closed
SB
172
Suntrust Banks
Georgia
– -$1.51M -111,431 Closed
MCM
173
Matarin Capital Management
New York
– -$1.46M -108,092 Closed
MSU
174
Mizuho Securities USA
New York
– -$1.02M -75,000 Closed
Citadel Advisors
175
Citadel Advisors
Florida
– -$834K -61,524 Closed
4 5 6
7
8

SCMP Hedge Fund Activity: Q1 2017 in Review

167 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2017, worth a combined $287M — down 16% from $340M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new SCMP positions and 30 closed out — a net gain of 10 holders — while 57 added to existing stakes and 47 trimmed.

The largest buyer was BlackRock, adding an estimated $41.4M. The largest seller was UBS O'Connor, exiting entirely with an estimated $6.78M sold.

  • 167 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2017, up from 165 in Q4 2016.
  • Funds reported $287M of Sucampo Pharmaceuticals, Inc. stock for Q1 2017, down 16% quarter-over-quarter.
  • 40 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2017 and 30 closed out, a net change of +10 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $41.4M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2017 was UBS O'Connor, an estimated $6.78M sold.

Based on aggregated 13F filings for Q1 2017.